Fusion Antibodies PLCHere is the public summary page for Fusion Antibodies PLC. Please login to see the complete information for Fusion Antibodies PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Fusion Antibodies PLC stacks up relative to its peers. |
| Darwin Score | +16 |
| Ticker | FAB |
| Latest Price | 0.18 GBP as of close on 15-Aug-2025 |
| 3 Month price range | 0.06 to 0.18 GBP |
| Market Capitalisation | 19.32Mn GBP |
| Country | UK |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Life Sciences Tools & Services |
| Sub-Industry | Life Sciences Tools & Services |
| Description | Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies primarily for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. It has a collaboration agreement with the National Cancer Institute for the use of OptiMAL for discovery of novel antibodies against targets selected by NCI. Fusion Antibodies plc was incorporated in 2000 and is headquartered in Belfast, the United Kingdom. See More ... |
| Company URL | https://www.fusionantibodies.com |
| See Darwins Full Analysis for Fusion Antibodies PLC |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Fusion Antibodies PLC. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +29 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -12 |
Alerts
There are 12 live alerts for Fusion Antibodies PLC.
- Price is at a 5d high. (Positive)
- Overbought - The 30 week RSI is +84.3. (Negative)
- Overbought - The 5 month RSI is +96.1. (Negative)
- Overbought - The 15 month RSI is +79.2. (Negative)
- Candle Pattern :: Inverted Hammer (Bearish) (Negative) (Negative)
- New High (6m). (Positive)
- 30d RSI Overbought. (Positive)
- 15d RSI Overbought. (Positive)
- New High (12m). (Positive)
- 5d RSI Overbought. (Positive)
- New High (1m). (Positive)
- New High (3m). (Positive)
Peer Comparison
There are 5 peers of Fusion Antibodies PLC.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Ergomed Plc (ERGO) | Life Sciences Tools & Services | +39 |
| IXICO PLC (IXI) | Life Sciences Tools & Services | +15 |
| Oxford Biodynamics PLC (OBD) | Life Sciences Tools & Services | -23 |
| Proteome Sciences PLC (PRM) | Life Sciences Tools & Services | -10 |
| PureTech Health plc (PRTC) | Life Sciences Tools & Services | -1 |
Share 
